Graco (GGG) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Graco (GGG), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks Investment Research • Sep 3, 2026

Graco Acquires Valco Melton, Strengthens Product Offerings

GGG's $447 million Valco Melton buyout expands adhesive dispensing and quality assurance capabilities while broadening its fluid handling portfolio.

Zacks Investment Research • Sep 1, 2026

Graco Inc. Closes Acquisition of Valco Melton

MINNEAPOLIS--(BUSINESS WIRE)--Graco Inc. (NYSE: GGG), a global leader in fluid and powder handling technologies, today announced it has completed its acquisition of Valco Melton, a global provider of adhesive application and quality assurance systems, for $447 million in cash. When adjusted for the present value of expected tax benefits of approximately $40 million, the net transaction value represents approximately 14x 2025 adjusted EBITDA and approximately 10x 2026 estimated full-year, synerg.

Business Wire • Aug 31, 2026

Graco (GGG) Upgraded to Buy: Here's What You Should Know

Graco (GGG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Aug 27, 2026

Top 50 High-Quality Dividend Growth Stocks For August 2026

I track a curated universe of 50 high-quality dividend growth stocks to identify timely, attractive entry points for long-term total return. The universe delivered a 10.44% YTD return through July, closely matching SPY but trailing SCHD, with several individual stocks significantly outperforming. Currently, 40 stocks in the universe offer a forward return estimate of at least 10%, with 25 appearing potentially undervalued based on free cash flow analysis.

Seeking Alpha • Aug 9, 2026

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.

Seeking Alpha • Jul 31, 2026

Madison Mid Cap Fund Q2 2026 Portfolio Activity

The top five contributors for the quarter were MKS, Amphenol, Arista Networks, Bio-Techne, and Waters. The bottom five detractors for the quarter were Ross Stores, Arch Capital, Copart, Gartner, and Brown & Brown. We purchased shares in Verisk Analytics, the dominant provider of data and analytics to property and casualty insurers in the U.S.

Seeking Alpha • Jul 31, 2026

Graco: Lack Of Organic Growth Leads To A Hold Rating

Graco has seen weak revenue per share growth recently but maintains robust margins and a healthy return on invested capital. Graco's dividend has grown for almost 25 years, and management still provides investors with solid dividend growth and a conservative payout ratio. Recent earnings highlight Q2 Non-GAAP earnings per share $0.10 above expectations, while revenue figures came up short of the consensus.

Seeking Alpha • Jul 28, 2026

Graco Q2 Earnings Call Highlights

Graco NYSE: GGG reported record second-quarter sales and earnings for fiscal 2026, with management pointing to improving order trends, stronger backlog and growth across all three business segments as reasons for confidence in the second half of the year.

MarketBeat • Jul 23, 2026

Graco Inc. (GGG) Q2 2026 Earnings Call Transcript

Graco Inc. (GGG) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jul 23, 2026